These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 22407471)
21. Guidelines for the use of antiretroviral agents in pediatric HIV infection--HRSA. Request for comments. Fed Regist; 1997 Sep; 62(189):51115-6. PubMed ID: 10175219 [TBL] [Abstract][Full Text] [Related]
22. [Drug combination therapy for children infected with HIV/AIDS--own experience]. Prandota-Schoepp A; Klinowska-Skupniewska J Przegl Epidemiol; 2001; 55 Suppl 3():135-41. PubMed ID: 11984940 [TBL] [Abstract][Full Text] [Related]
23. Antiretroviral drug resistance among HIV-1 infected children failing treatment. Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814 [TBL] [Abstract][Full Text] [Related]
24. Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy. Luis Jiménez J; Resino S; Martinez-Colom A; Bellón JM; Angeles Muñoz-Fernández M; J Antimicrob Chemother; 2005 Dec; 56(6):1081-6. PubMed ID: 16195257 [TBL] [Abstract][Full Text] [Related]
25. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients. Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618 [TBL] [Abstract][Full Text] [Related]
26. [Antiretroviral therapy in 2004]. Jablonowski H MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049 [TBL] [Abstract][Full Text] [Related]
27. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries. Puthanakit T; Bunupuradah T Curr Opin HIV AIDS; 2010 Jan; 5(1):12-7. PubMed ID: 20046143 [TBL] [Abstract][Full Text] [Related]
28. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006. Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758 [TBL] [Abstract][Full Text] [Related]
29. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR; Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042 [TBL] [Abstract][Full Text] [Related]
31. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Center for Disease Control and Prevention. MMWR Recomm Rep; 1998 Apr; 47(RR-4):1-43. PubMed ID: 9572665 [TBL] [Abstract][Full Text] [Related]
33. Variations in HIV-RNA viral load and CD4 counts of infants and children receiving antiretroviral drug therapy. Sever JL; Rakusan TA; Loechelt B; Schutzbank T; Zamer S; O'Donnell R; Price MV J Clin Virol; 1999 Jan; 12(1):71-4. PubMed ID: 10073416 [No Abstract] [Full Text] [Related]
34. Treatment of HIV infection: Swedish recommendations 2009. Josephson F; Albert J; Flamholc L; Gisslén M; Karlström O; Moberg L; Navér L; Svedhem V; Svennerholm B; Sönnerborg A; ; Scand J Infect Dis; 2009; 41(11-12):788-807. PubMed ID: 19922061 [TBL] [Abstract][Full Text] [Related]
35. Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy. Crowell CS; Malee KM; Yogev R; Muller WJ Rev Med Virol; 2014 Sep; 24(5):316-31. PubMed ID: 24806816 [TBL] [Abstract][Full Text] [Related]
36. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. Carpenter CC; Cooper DA; Fischl MA; Gatell JM; Gazzard BG; Hammer SM; Hirsch MS; Jacobsen DM; Katzenstein DA; Montaner JS; Richman DD; Saag MS; Schechter M; Schooley RT; Thompson MA; Vella S; Yeni PG; Volberding PA JAMA; 2000 Jan; 283(3):381-90. PubMed ID: 10647802 [TBL] [Abstract][Full Text] [Related]
37. Misclassification of Antiretroviral Treatment Failure Using WHO 2006 and 2010/2013 Immunologic Criteria in HIV-Infected Children and Adolescents in Western Kenya. Dufort EM; DeLong AK; Mann M; Nyandiko WM; Ayaya SO; Hogan JW; Kantor R J Pediatric Infect Dis Soc; 2017 Sep; 6(3):285-288. PubMed ID: 27130578 [TBL] [Abstract][Full Text] [Related]
39. Constraints and prospects in the management of pediatric HIV/AIDS. Temiye EO; Akinsulie AO; Ezeaka CV; Adetifa IM; Iroha EO; Grange AO; J Natl Med Assoc; 2006 Aug; 98(8):1252-9. PubMed ID: 16916121 [TBL] [Abstract][Full Text] [Related]
40. Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection. Phillips AN; Walker AS AIDS; 2004 Feb; 18(3):365-70. PubMed ID: 15090787 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]